The role of the novel exopolyphosphatase MT0516 in Mycobacterium tuberculosis drug tolerance and persistence
- PMID: 22132215
- PMCID: PMC3221697
- DOI: 10.1371/journal.pone.0028076
The role of the novel exopolyphosphatase MT0516 in Mycobacterium tuberculosis drug tolerance and persistence
Abstract
Inorganic polyphosphate (poly P) has been postulated to play a regulatory role in the transition to bacterial persistence. In bacteria, poly P balance in the cell is maintained by the hydrolysis activity of the exopolyphosphatase PPX. However, the Mycobacterium tuberculosis PPX has not been characterized previously. Here we show that recombinant MT0516 hydrolyzes poly P, and an MT0516-deficient M. tuberculosis mutant exhibits elevated intracellular levels of poly P and increased expression of the genes mprB, sigE, and rel relative to the isogenic wild-type strain, indicating poly P-mediated signaling. Deficiency of MT0516 resulted in decelerated growth during logarithmic-phase in axenic cultures, and tolerance to the cell wall-active drug isoniazid. The MT0516-deficient mutant showed a significant survival defect in activated human macrophages and reduced persistence in the lungs of guinea pigs. We conclude that exopolyphosphatase is required for long-term survival of M. tuberculosis in necrotic lung lesions.
Conflict of interest statement
Figures





Similar articles
-
Deficiency of the novel exopolyphosphatase Rv1026/PPX2 leads to metabolic downshift and altered cell wall permeability in Mycobacterium tuberculosis.mBio. 2015 Mar 17;6(2):e02428. doi: 10.1128/mBio.02428-14. mBio. 2015. PMID: 25784702 Free PMC article.
-
The polyphosphate kinase gene ppk2 is required for Mycobacterium tuberculosis inorganic polyphosphate regulation and virulence.mBio. 2013 May 21;4(3):e00039-13. doi: 10.1128/mBio.00039-13. mBio. 2013. PMID: 23695835 Free PMC article.
-
Stringent Response Factors PPX1 and PPK2 Play an Important Role in Mycobacterium tuberculosis Metabolism, Biofilm Formation, and Sensitivity to Isoniazid In Vivo.Antimicrob Agents Chemother. 2016 Oct 21;60(11):6460-6470. doi: 10.1128/AAC.01139-16. Print 2016 Nov. Antimicrob Agents Chemother. 2016. PMID: 27527086 Free PMC article.
-
[Progress in polyphosphate and related metabolizing enzymes].Sheng Li Ke Xue Jin Zhan. 2011 Jun;42(3):181-7. Sheng Li Ke Xue Jin Zhan. 2011. PMID: 21932515 Review. Chinese.
-
[Polyphosphate and its physiological function in Mycobacteria - A review].Wei Sheng Wu Xue Bao. 2016 Dec 4;56(12):1840-6. Wei Sheng Wu Xue Bao. 2016. PMID: 29741848 Review. Chinese.
Cited by
-
Inorganic polyphosphate accumulation suppresses the dormancy response and virulence in Mycobacterium tuberculosis.J Biol Chem. 2019 Jul 12;294(28):10819-10832. doi: 10.1074/jbc.RA119.008370. Epub 2019 May 21. J Biol Chem. 2019. Retraction in: J Biol Chem. 2020 Oct 23;295(43):14791. doi: 10.1074/jbc.W120.016194. PMID: 31113860 Free PMC article. Retracted.
-
Gene Enrichment Analysis Reveals Major Regulators of Mycobacterium tuberculosis Gene Expression in Two Models of Antibiotic Tolerance.Front Microbiol. 2018 Apr 4;9:610. doi: 10.3389/fmicb.2018.00610. eCollection 2018. Front Microbiol. 2018. PMID: 29670589 Free PMC article.
-
Establishing Virulence Associated Polyphosphate Kinase 2 as a drug target for Mycobacterium tuberculosis.Sci Rep. 2016 Jun 9;6:26900. doi: 10.1038/srep26900. Sci Rep. 2016. PMID: 27279366 Free PMC article.
-
Oxidative stress protection by polyphosphate--new roles for an old player.Curr Opin Microbiol. 2015 Apr;24:1-6. doi: 10.1016/j.mib.2014.12.004. Epub 2015 Jan 10. Curr Opin Microbiol. 2015. PMID: 25589044 Free PMC article. Review.
-
Mechanisms of Antibiotic Tolerance in Mycobacterium avium Complex: Lessons From Related Mycobacteria.Front Microbiol. 2020 Sep 30;11:573983. doi: 10.3389/fmicb.2020.573983. eCollection 2020. Front Microbiol. 2020. PMID: 33101247 Free PMC article. Review.
References
-
- Fauci AS. Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research. J Infect Dis. 2008;197:1493–1498. - PubMed
-
- Nuermberger E, Bishai WR, Grosset JH. Latent tuberculosis infection. Semin Respir Crit Care Med. 2004;25:317–336. - PubMed
-
- Opie EL, Aronson JD. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch Pathol Lab Med. 1927;4:1–21.
-
- Haapanen JH, Kass I, Gensini G, Middlebrook G. Studies on the gaseous content of tuberculous cavities. Am Rev Respir Dis. 1959;80:1–5. - PubMed
-
- Gomez JE, McKinney JD. Persistence and drug tolerance. In: Rom WN, Garay SM, editors. Tuberculosis. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. pp. 101–114.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical